Our business is focused on rapid development of pharmaceutical products targeting excessive mtROS and protecting mitochondrial bioenergetics. This novel biological approach has generated promising drug candidates for treatment of many age-related disorders. Mitotech is developing its technology with a goal to help millions of patients suffering from ophthalmic, neurodegenerative, cardiovascular, metabolic, autoimmune and rare genetic disorders.

Drug discovery pipeline